Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

CytRx Corporation (CYTR)

0.08936   -0.011 (-10.64%) 08-18 06:36
Open: 0.0998 Pre. Close: 0.1
High: 0.0998 Low: 0.08936
Volume: 43,879 Market Cap: 4(M)
CytRx Corporation, a biopharmaceutical research and development company, focuses on oncology and rare diseases. It engages in the discovery, research, and clinical development of novel anti-cancer drug candidates that employ novel linker technologies to enhance the accumulation and release of cytotoxic anti-cancer agents at the tumor. The company's lead candidates include linker activated drug release (LADR) -7, LADR-8, LADR-9, and LADR-10; and Aldoxorubicin, a conjugate of prescribed cytotoxin agent doxorubicin that binds to circulating albumin in the bloodstream and to concentrate the drug at the site of the tumor. It also provides ACDx, an albumin companion diagnostic product to identify patients with cancer who are most likely to benefit from treatment with these drug candidates. CytRx Corporation was incorporated in 1985 and is headquartered in Los Angeles, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.1 - 0.1 0.1 - 0.1
Low: 0.09 - 0.09 0.09 - 0.09
Close: 0.09 - 0.09 0.09 - 0.09

Technical analysis

as of: 2022-08-17 4:22:33 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 0.12     One year: 0.15
Support: Support1: 0.07    Support2: 0.06
Resistance: Resistance1: 0.11    Resistance2: 0.12
Pivot: 0.09
Moving Average: MA(5): 0.09     MA(20): 0.09
MA(100): 0.13     MA(250): 0.37
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 28.1     %D(3): 37.8
RSI: RSI(14): 45
52-week: High: 0.86  Low: 0.05
Average Vol(K): 3-Month: 62 (K)  10-Days: 69 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ CYTR ] has closed above bottom band by 26.1%. Bollinger Bands are 59.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 76 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 09 Aug 2022
CytRx Welcomes Cary J. Claiborne to the CytRx Board of Directors - Yahoo Finance

Tue, 09 Aug 2022
Contrasting ImmunityBio (NASDAQ:IBRX) and CytRx (NASDAQ:CYTR) - Defense World

Tue, 09 Aug 2022
CytRx (NASDAQ:CYTR) Earns Hold Rating from Analysts at - Defense World

Mon, 01 Aug 2022
CytRx (NASDAQ:CYTR) Coverage Initiated by Analysts at - Defense World

Tue, 17 May 2022
CytRx Highlights Strategic Purchase of Arimoclomol by KemPharm, Inc. - Yahoo Finance

Wed, 09 Mar 2022
CytRx Announces Integration of Wholly Owned Subsidiary Centurion BioPharma and Corporate Governance Updates - Yahoo Finance

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Underperform
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  OTC
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 45 (M)
Shares Float 34 (M)
% Held by Insiders 14.1 (%)
% Held by Institutions 9.4 (%)
Shares Short 294 (K)
Shares Short P.Month 428 (K)

Stock Financials

EPS -0.36
EPS Est Next Qtl 0
EPS Est This Year -0.5
EPS Est Next Year -0.41
Book Value (p.s.) 0.02
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) -43.6
Return on Equity (ttm) -242.8
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -0.14
Qtrly Earnings Growth 0
Operating Cash Flow -13 (M)
Levered Free Cash Flow -4 (M)

Stock Valuations

PE Ratio -0.26
PEG Ratio 0
Price to Book value 2.97
Price to Sales 0
Price to Cash Flow -0.31

Stock Dividends

Dividend 10.46
Forward Dividend 0
Dividend Yield 11705.4%
Dividend Pay Date 2017-10-31
Ex-Dividend Date 2008-07-03
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.